Neogen Corporation

Neogen Corporation

NEOGยทNASDAQ

$8.81

-1.2%
HealthcareMedical - Diagnostics & Research

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

At a Glance

Live Snapshot
Market Cap$1.92B
EPS-5.0300
P/E Ratio-1.75
Earnings Date07/28/2026
0.28%
Return on Invested Capital
-76%
3Y-95.0%
5Y-96.0%
10Y-97.0%
-52.72%
Return on Equity
17498%
3Y-1069.0%
5Y-743.0%
10Y-683.0%
-31.71%
Return on Assets
15211%
3Y-752.0%
5Y-525.0%
10Y-492.0%
Neogen Corporation

Neogen Corporation Management Team

NEOG ยท NASDAQ
SD

Sarah Demey

Administrative Manager

MA

Ms. Amy M. Rocklin Ph.D.

Chief Legal & Compliance Officer and Corporate Secretary

Compensation

$564,703

Born 1972(Age 54)
female
MD

Mr. David H. Naemura

Chief Operating Officer & Chief Financial Officer

Compensation

$810,651

Born 1970(Age 56)
male
DJ

Dr. Jason W. Lilly M.B.A., Ph.D.

Chief Scientific Officer

Compensation

$476,992

Born 1974(Age 52)
MB

Mr. Bill Waelke

Head of Investor Relations

male
MJ

Mr. John Edward Adent

President, Chief Executive Officer & Director

Compensation

$1,221,352

Born 1968(Age 58)
male
MJ

Mr. John Moylan

Vice President, Corporate Controller & Chief Accounting Officer

male
neog

Neogen Corporation Insider Positioning

NEOG ยท NASDAQ

During the last 12 months, insiders have purchased $3K worth of NEOG shares, with no selling activity reported.

3 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

3-6 Months

Bought

209

2.01K

Sold

0

0.00

Net Activity

+2K

+$2K

6-9 Months

Bought

177

1.11K

Sold

0

0.00

Net Activity

+1K

+$1K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

1
NM

Nassif Mikheal

Director, Officer: Ceo

386 sharesโ€ข5 transactions

$3K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $3K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

โˆž:1

Perfect buy/sell ratio. Only buying activity with zero sellingโ€”the most bullish possible insider signal.

Insider Participation

High Buying

1 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Unanimous insider buying: Zero selling combined with active buying is rare and typically very bullish. Insiders appear to see significant upside with limited downside risk.

SEC Filings

NEOG - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2025

N/A

September 12, 2025
September 12, 2025
2025
DEF 14A

DEF 14A 2024

N/A

September 13, 2024
October 24, 2024
2024
DEF 14A

DEF 14A 2023

N/A

September 18, 2023
October 25, 2023
2023
DEF 14A

DEF 14A 2022

N/A

August 30, 2022
October 06, 2022
2022
DEF 14A

DEF 14A 2021

N/A

August 31, 2021
October 07, 2021
2021
DEF 14A

DEF 14A 2020

N/A

August 31, 2020
October 08, 2020
2020
DEF 14A

DEF 14A 2019

N/A

August 27, 2019
October 03, 2019
2019
DEF 14A

DEF 14A 2018

N/A

August 28, 2018
October 04, 2018
2018
DEF 14A

DEF 14A 2017

N/A

August 30, 2017
October 05, 2017
2017
DEF 14A

DEF 14A 2016

N/A

August 31, 2016
October 06, 2016
2016
Showing 1 to 10 of 31 filings